• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛇孢菌素M及其类似物,伊维菌素结合的非竞争性抑制剂,具有杀线虫活性。

Ophiobolin M and analogues, noncompetitive inhibitors of ivermectin binding with nematocidal activity.

作者信息

Tsipouras A, Adefarati A A, Tkacz J S, Frazier E G, Rohrer S P, Birzin E, Rosegay A, Zink D L, Goetz M A, Singh S B, Schaeffer J M

机构信息

Department of Cell Biochemistry and Physiology, Merck Research Laboratories, Rahway, NJ 07065, USA.

出版信息

Bioorg Med Chem. 1996 Apr;4(4):531-6. doi: 10.1016/0968-0896(96)00036-3.

DOI:10.1016/0968-0896(96)00036-3
PMID:8735840
Abstract

A series of ophiobolins were isolated from a fungal extract based on their nematocidal activity. These compounds are non-competitive inhibitors of ivermectin binding to membranes prepared from the free-living nematode, Caenorhabditis elegans, with an inhibition constant of 15 microM. The ophiobolins which were most potent in the biological assays, ophiobolin C and ophiobolin M, were also the most potent compounds when evaluated in a C. elegans motility assay. These data suggest that the nematocidal activity of the ophiobolins is mediated via an interaction with the ivermectin binding site. The isolation, structure and biological activity of ophiobolins have been described.

摘要

基于杀线虫活性,从一种真菌提取物中分离出了一系列蛇孢菌素。这些化合物是非竞争性抑制剂,可抑制伊维菌素与从自由生活线虫秀丽隐杆线虫制备的膜结合,抑制常数为15微摩尔。在生物学试验中最有效的蛇孢菌素,即蛇孢菌素C和蛇孢菌素M,在秀丽隐杆线虫运动试验中评估时也是最有效的化合物。这些数据表明,蛇孢菌素的杀线虫活性是通过与伊维菌素结合位点的相互作用介导的。蛇孢菌素的分离、结构和生物活性已有描述。

相似文献

1
Ophiobolin M and analogues, noncompetitive inhibitors of ivermectin binding with nematocidal activity.蛇孢菌素M及其类似物,伊维菌素结合的非竞争性抑制剂,具有杀线虫活性。
Bioorg Med Chem. 1996 Apr;4(4):531-6. doi: 10.1016/0968-0896(96)00036-3.
2
Ophiobolin E and 8-epi-ophiobolin J produced by Drechslera gigantea, a potential mycoherbicide of weedy grasses.由巨大德氏霉产生的蛇孢菌素E和8-表-蛇孢菌素J,一种潜在的杂草真菌除草剂。
Phytochemistry. 2006 Oct;67(20):2281-7. doi: 10.1016/j.phytochem.2006.07.016. Epub 2006 Sep 7.
3
Microbial metabolites of ophiobolin A and antimicrobial evaluation of ophiobolins.蛇孢菌素A的微生物代谢产物及蛇孢菌素的抗菌活性评价
J Nat Prod. 1995 Jan;58(1):74-81. doi: 10.1021/np50115a009.
4
Nematocidal activity of MK-801 analogs and related drugs. Structure-activity relationships.MK-801类似物及相关药物的杀线虫活性。构效关系。
Biochem Pharmacol. 1994 Jul 19;48(2):411-8. doi: 10.1016/0006-2952(94)90114-7.
5
The mechanism of action of avermectins in Caenorhabditis elegans: correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity.阿维菌素在秀丽隐杆线虫中的作用机制:谷氨酸敏感氯离子电流激活、膜结合与生物活性之间的相关性。
J Parasitol. 1995 Apr;81(2):286-94.
6
Unusual terpenylated acylphloroglucinols from Dryopteris wallichiana.从墙鳞毛蕨中分离得到的新颖萜基酰基间苯三酚。
Phytochemistry. 2012 Aug;80:115-22. doi: 10.1016/j.phytochem.2012.04.017. Epub 2012 Jun 1.
7
Cochlioquinone A, a nematocidal agent which competes for specific [3H]ivermectin binding sites.旋覆花醌A,一种可竞争特异性[3H]伊维菌素结合位点的杀线虫剂。
J Antibiot (Tokyo). 1990 Sep;43(9):1179-82. doi: 10.7164/antibiotics.43.1179.
8
Novel nematocidal agents from Curcuma comosa.
J Nat Prod. 1994 Feb;57(2):230-5. doi: 10.1021/np50104a006.
9
Herbicidal potential of ophiobolins produced by Drechslera gigantea.巨大德氏霉产生的蛇孢菌素的除草潜力
J Agric Food Chem. 2006 Mar 8;54(5):1779-83. doi: 10.1021/jf052843l.
10
[Pharmacological effects of ivermectin, an antiparasitic agent for intestinal strongyloidiasis: its mode of action and clinical efficacy].[伊维菌素(一种用于肠道类圆线虫病的抗寄生虫药物)的药理作用:其作用方式及临床疗效]
Nihon Yakurigaku Zasshi. 2003 Dec;122(6):527-38. doi: 10.1254/fpj.122.527.

引用本文的文献

1
Derivatization of ophiobolin A and cytotoxicity toward breast and glioblastoma cancer stem cells: Varying the ketone and unsaturated aldehyde moieties.蛇孢菌素A的衍生化及其对乳腺癌和胶质母细胞瘤癌症干细胞的细胞毒性:改变酮和不饱和醛部分。
Bioorg Med Chem Lett. 2025 May 1;120:130112. doi: 10.1016/j.bmcl.2025.130112. Epub 2025 Jan 27.
2
Therapeutic vulnerabilities of cancer stem cells and effects of natural products.癌症干细胞的治疗弱点和天然产物的作用。
Nat Prod Rep. 2023 Aug 16;40(8):1432-1456. doi: 10.1039/d3np00002h.
3
Characterization and phytotoxicity of ophiobolins produced by .
由……产生的蛇孢菌素的特性及植物毒性
Mycoscience. 2021 Jan 20;62(1):64-70. doi: 10.47371/mycosci.2020.11.002. eCollection 2021.
4
Discovery and characterization of a terpene biosynthetic pathway featuring a norbornene-forming Diels-Alderase.发现并表征了一种具有降蒈烯形成 Diels-Alderase 的萜类生物合成途径。
Nat Commun. 2022 May 11;13(1):2568. doi: 10.1038/s41467-022-30288-6.
5
New Ophiobolin Derivatives from the Marine Fungus and Their Cytotoxicities against Cancer Cells.海洋真菌中新海鞘素衍生物及其对癌细胞的细胞毒性。
Mar Drugs. 2019 Jun 11;17(6):346. doi: 10.3390/md17060346.
6
The Biological Activities of Sesterterpenoid-Type Ophiobolins.倍半萜型蛇孢菌素的生物活性。
Mar Drugs. 2017 Jul 18;15(7):229. doi: 10.3390/md15070229.
7
Metabolites from nematophagous fungi and nematicidal natural products from fungi as alternatives for biological control. Part II: metabolites from nematophagous basidiomycetes and non-nematophagous fungi.线虫寄生真菌的代谢产物及真菌源杀线虫天然产物作为生物防治的替代物。第二部分:线虫寄生担子菌和非线虫寄生真菌的代谢产物
Appl Microbiol Biotechnol. 2016 May;100(9):3813-24. doi: 10.1007/s00253-015-7234-5. Epub 2016 Jan 4.
8
Bio-activity and dereplication-based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells.基于生物活性和去重复的方法发现针对白血病细胞的蛇孢菌素和其他真菌次级代谢产物。
Molecules. 2013 Nov 26;18(12):14629-50. doi: 10.3390/molecules181214629.
9
Studies towards the total synthesis of di- and sesterterpenes with dicyclopenta[a,d]cyclooctane skeletons. Three-component approach to the A/B rings building block.具有双环戊[a,d]环辛烷骨架的二萜和倍半萜全合成研究。构建A/B环结构单元的三组分方法。
Molecules. 2005 Sep 30;10(9):1084-100. doi: 10.3390/10091084.
10
Isolation, structure, and HIV-1-integrase inhibitory activity of structurally diverse fungal metabolites.
J Ind Microbiol Biotechnol. 2003 Dec;30(12):721-31. doi: 10.1007/s10295-003-0101-x. Epub 2004 Jan 9.